Ian E. Krop, MD, PhD
- Internal Medicine, 1999
- Medical Oncology, 2002
- Dana-Farber/Partners CancerCare, Hematology/Oncology
- Johns Hopkins University School of Medicine, Internal Medicine
- Johns Hopkins University School of Medicine
Ian E. Krop, M.D., Ph.D., Chief Scientific Officer for the Translational Breast Cancer Research Consortium
Dr. Krop is a clinical translational medical oncologist whose primary research focuses on understanding and overcoming mechanisms of resistance to HER2-directed therapies. Dr. Krop played a major role in developing T-DM1 (Kadcyla or trastuzumab emtansine), a new...